This retrospective observational study examines dapagliflozin's effects on kidney protection in patients with diabetes, indicating potential benefits for this population.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: